APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Microbiology Testing

Compare research editions
View pricing & licenses

Selected research

Industry Research

Pharmaceutical Microbiology Testing Industry Research Report 2026

4 June 2026141 pages

Choose your research edition.

Industry ResearchPharmaceutical Microbiology Testing Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Microbiology Testing Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Microbiology Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Microbiology Testing Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Microbiology Testing Market Analysis and Forecast 2026-2032223 pages · $4,950 USD

Market perspective

The global Pharmaceutical Microbiology Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Pharmaceutical Microbiology Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharmaceutical Microbiology Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharmaceutical Microbiology Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharmaceutical Microbiology Testing include Eurofins Scientific, Charles River Laboratories, SGS, WuXi AppTec, Nelson Labs, Pace Analytical, Thermo Fisher Scientific, Merck KGaA / MilliporeSigma and bioMérieux, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Pharmaceutical Microbiology Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmaceutical Microbiology Testing.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Pharmaceutical Microbiology Testing Market by Company

Eurofins Scientific

Charles River Laboratories

SGS

WuXi AppTec

Nelson Labs

Pace Analytical

Thermo Fisher Scientific

Merck KGaA / MilliporeSigma

bioMérieux

Sartorius

STERIS

Intertek

ALS Limited

Microbac Laboratories

Alcami

Almac Group

Labcorp Drug Development

Element Materials Technology

Toxikon

Aurigene Pharmaceutical Services

Toray Research Center

Centre Testing International Group

Pony Testing International Group

Sumika Chemical Analysis Service

CMIC Group

LSI Medience

Pharmaceutical Microbiology Testing Segment by Type

Culture-Based Testing

Rapid Microbial Testing

Molecular Testing

Automated Microbiology Testing

Others

Pharmaceutical Microbiology Testing Segment by Application

Pharmaceutical Industry

CRO/CDMO

Medical Device

Others

Pharmaceutical Microbiology Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Microbiology Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Microbiology Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Microbiology Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Pharmaceutical Microbiology Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pharmaceutical Microbiology Testing Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Pharmaceutical Microbiology Testing Revenue Market Share by Type (2021-2026) Table 7. Global Pharmaceutical Microbiology Testing Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Pharmaceutical Microbiology Testing Revenue Market Share by Type (2027-2032) Table 9. Global Pharmaceutical Microbiology Testing Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Pharmaceutical Microbiology Testing Revenue Market Share by Application (2021-2026) Table 11. Global Pharmaceutical Microbiology Testing Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Pharmaceutical Microbiology Testing Revenue Market Share by Application (2027-2032) Table 13. Global Pharmaceutical Microbiology Testing Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Pharmaceutical Microbiology Testing Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Pharmaceutical Microbiology Testing Market Share by Region (2021-2026) Table 16. Global Pharmaceutical Microbiology Testing Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Pharmaceutical Microbiology Testing Market Share by Region (2027-2032) Table 18. Pharmaceutical Microbiology Testing Industry Trends Table 19. Pharmaceutical Microbiology Testing Industry Drivers Table 20. Pharmaceutical Microbiology Testing Industry Opportunities and Challenges Table 21. Pharmaceutical Microbiology Testing Market Restraints Table 22. Global Top Pharmaceutical Microbiology Testing Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Pharmaceutical Microbiology Testing Revenue Market Share by Players (2021-2026) Table 24. Global Pharmaceutical Microbiology Testing Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Pharmaceutical Microbiology Testing, Headquarters and Area Served Table 26. Global Pharmaceutical Microbiology Testing Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Pharmaceutical Microbiology Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Pharmaceutical Microbiology Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Pharmaceutical Microbiology Testing Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Pharmaceutical Microbiology Testing Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Pharmaceutical Microbiology Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Pharmaceutical Microbiology Testing Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Pharmaceutical Microbiology Testing Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Pharmaceutical Microbiology Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Pharmaceutical Microbiology Testing Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Pharmaceutical Microbiology Testing Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Pharmaceutical Microbiology Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Pharmaceutical Microbiology Testing Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Pharmaceutical Microbiology Testing Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Pharmaceutical Microbiology Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Pharmaceutical Microbiology Testing Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Pharmaceutical Microbiology Testing Market Size by Country (2027-2032) & (US$ Million) Table 45. Eurofins Scientific Company Information Table 46. Eurofins Scientific Business Overview Table 47. Eurofins Scientific Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 48. Eurofins Scientific Pharmaceutical Microbiology Testing Product Portfolio Table 49. Eurofins Scientific Recent Developments Table 50. Charles River Laboratories Company Information Table 51. Charles River Laboratories Business Overview Table 52. Charles River Laboratories Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 53. Charles River Laboratories Pharmaceutical Microbiology Testing Product Portfolio Table 54. Charles River Laboratories Recent Developments Table 55. SGS Company Information Table 56. SGS Business Overview Table 57. SGS Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 58. SGS Pharmaceutical Microbiology Testing Product Portfolio Table 59. SGS Recent Developments Table 60. WuXi AppTec Company Information Table 61. WuXi AppTec Business Overview Table 62. WuXi AppTec Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 63. WuXi AppTec Pharmaceutical Microbiology Testing Product Portfolio Table 64. WuXi AppTec Recent Developments Table 65. Nelson Labs Company Information Table 66. Nelson Labs Business Overview Table 67. Nelson Labs Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 68. Nelson Labs Pharmaceutical Microbiology Testing Product Portfolio Table 69. Nelson Labs Recent Developments Table 70. Pace Analytical Company Information Table 71. Pace Analytical Business Overview Table 72. Pace Analytical Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 73. Pace Analytical Pharmaceutical Microbiology Testing Product Portfolio Table 74. Pace Analytical Recent Developments Table 75. Thermo Fisher Scientific Company Information Table 76. Thermo Fisher Scientific Business Overview Table 77. Thermo Fisher Scientific Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 78. Thermo Fisher Scientific Pharmaceutical Microbiology Testing Product Portfolio Table 79. Thermo Fisher Scientific Recent Developments Table 80. Merck KGaA / MilliporeSigma Company Information Table 81. Merck KGaA / MilliporeSigma Business Overview Table 82. Merck KGaA / MilliporeSigma Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 83. Merck KGaA / MilliporeSigma Pharmaceutical Microbiology Testing Product Portfolio Table 84. Merck KGaA / MilliporeSigma Recent Developments Table 85. bioMérieux Company Information Table 86. bioMérieux Business Overview Table 87. bioMérieux Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 88. bioMérieux Pharmaceutical Microbiology Testing Product Portfolio Table 89. bioMérieux Recent Developments Table 90. Sartorius Company Information Table 91. Sartorius Business Overview Table 92. Sartorius Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 93. Sartorius Pharmaceutical Microbiology Testing Product Portfolio Table 94. Sartorius Recent Developments Table 95. STERIS Company Information Table 96. STERIS Business Overview Table 97. STERIS Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 98. STERIS Pharmaceutical Microbiology Testing Product Portfolio Table 99. STERIS Recent Developments Table 100. Intertek Company Information Table 101. Intertek Business Overview Table 102. Intertek Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 103. Intertek Pharmaceutical Microbiology Testing Product Portfolio Table 104. Intertek Recent Developments Table 105. ALS Limited Company Information Table 106. ALS Limited Business Overview Table 107. ALS Limited Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 108. ALS Limited Pharmaceutical Microbiology Testing Product Portfolio Table 109. ALS Limited Recent Developments Table 110. Microbac Laboratories Company Information Table 111. Microbac Laboratories Business Overview Table 112. Microbac Laboratories Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 113. Microbac Laboratories Pharmaceutical Microbiology Testing Product Portfolio Table 114. Microbac Laboratories Recent Developments Table 115. Alcami Company Information Table 116. Alcami Business Overview Table 117. Alcami Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 118. Alcami Pharmaceutical Microbiology Testing Product Portfolio Table 119. Alcami Recent Developments Table 120. Almac Group Company Information Table 121. Almac Group Business Overview Table 122. Almac Group Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 123. Almac Group Pharmaceutical Microbiology Testing Product Portfolio Table 124. Almac Group Recent Developments Table 125. Labcorp Drug Development Company Information Table 126. Labcorp Drug Development Business Overview Table 127. Labcorp Drug Development Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 128. Labcorp Drug Development Pharmaceutical Microbiology Testing Product Portfolio Table 129. Labcorp Drug Development Recent Developments Table 130. Element Materials Technology Company Information Table 131. Element Materials Technology Business Overview Table 132. Element Materials Technology Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 133. Element Materials Technology Pharmaceutical Microbiology Testing Product Portfolio Table 134. Element Materials Technology Recent Developments Table 135. Toxikon Company Information Table 136. Toxikon Business Overview Table 137. Toxikon Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 138. Toxikon Pharmaceutical Microbiology Testing Product Portfolio Table 139. Toxikon Recent Developments Table 140. Aurigene Pharmaceutical Services Company Information Table 141. Aurigene Pharmaceutical Services Business Overview Table 142. Aurigene Pharmaceutical Services Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 143. Aurigene Pharmaceutical Services Pharmaceutical Microbiology Testing Product Portfolio Table 144. Aurigene Pharmaceutical Services Recent Developments Table 145. Toray Research Center Company Information Table 146. Toray Research Center Business Overview Table 147. Toray Research Center Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 148. Toray Research Center Pharmaceutical Microbiology Testing Product Portfolio Table 149. Toray Research Center Recent Developments Table 150. Centre Testing International Group Company Information Table 151. Centre Testing International Group Business Overview Table 152. Centre Testing International Group Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 153. Centre Testing International Group Pharmaceutical Microbiology Testing Product Portfolio Table 154. Centre Testing International Group Recent Developments Table 155. Pony Testing International Group Company Information Table 156. Pony Testing International Group Business Overview Table 157. Pony Testing International Group Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 158. Pony Testing International Group Pharmaceutical Microbiology Testing Product Portfolio Table 159. Pony Testing International Group Recent Developments Table 160. Sumika Chemical Analysis Service Company Information Table 161. Sumika Chemical Analysis Service Business Overview Table 162. Sumika Chemical Analysis Service Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 163. Sumika Chemical Analysis Service Pharmaceutical Microbiology Testing Product Portfolio Table 164. Sumika Chemical Analysis Service Recent Developments Table 165. CMIC Group Company Information Table 166. CMIC Group Business Overview Table 167. CMIC Group Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 168. CMIC Group Pharmaceutical Microbiology Testing Product Portfolio Table 169. CMIC Group Recent Developments Table 170. LSI Medience Company Information Table 171. LSI Medience Business Overview Table 172. LSI Medience Revenue in Pharmaceutical Microbiology Testing Business (2021-2026) & (US$ Million) Table 173. LSI Medience Pharmaceutical Microbiology Testing Product Portfolio Table 174. LSI Medience Recent Developments Table 175. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Pharmaceutical Microbiology Testing Product Image Figure 5. Global Pharmaceutical Microbiology Testing Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Pharmaceutical Microbiology Testing Market Share by Type: 2025 VS 2032 Figure 7. Culture-Based Testing Product Figure 8. Rapid Microbial Testing Product Figure 9. Molecular Testing Product Figure 10. Automated Microbiology Testing Product Figure 11. Others Product Figure 12. Global Pharmaceutical Microbiology Testing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Pharmaceutical Microbiology Testing Market Share by Application: 2025 VS 2032 Figure 14. Pharmaceutical Industry Product Figure 15. CRO/CDMO Product Figure 16. Medical Device Product Figure 17. Others Product Figure 18. Global Pharmaceutical Microbiology Testing Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 19. Global Pharmaceutical Microbiology Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 20. Global Pharmaceutical Microbiology Testing Market Share by Region: 2025 VS 2032 Figure 21. Global Pharmaceutical Microbiology Testing Market Share by Players in 2025 Figure 22. Global Pharmaceutical Microbiology Testing Manufacturers Established Date Figure 23. Global Top 5 and 10 Pharmaceutical Microbiology Testing Players Market Share by Revenue in 2025 Figure 24. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. North America Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Pharmaceutical Microbiology Testing Market Share by Country (2021-2032) Figure 27. United States Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Canada Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Mexico Pharmaceutical Microbiology Testing Market Share by Country (2021-2032) Figure 30. Europe Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Pharmaceutical Microbiology Testing Market Share by Country (2021-2032) Figure 32. Germany Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. France Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. U.K. Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Italy Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Spain Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Russia Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Netherlands Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Nordic Countries Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Asia-Pacific Pharmaceutical Microbiology Testing Market Share by Country (2021-2032) Figure 42. China Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. Japan Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. South Korea Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. India Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. India Pharmaceutical Microbiology Testing Market Share by Country (2021-2032) Figure 47. Australia Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. China Taiwan Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. Southeast Asia Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. South America Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. South America Pharmaceutical Microbiology Testing Market Share by Country (2021-2032) Figure 52. Brazil Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Argentina Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Chile Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. Colombia Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 56. Peru Pharmaceutical Microbiology Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 57. Eurofins Scientific Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026) Figure 58. Charles River Laboratories Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026) Figure 59. SGS Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026) Figure 60. WuXi AppTec Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026) Figure 61. Nelson Labs Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026) Figure 62. Pace Analytical Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026) Figure 63. Thermo Fisher Scientific Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026) Figure 64. Merck KGaA / MilliporeSigma Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026) Figure 65. bioMérieux Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026) Figure 66. Sartorius Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026) Figure 67. STERIS Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026) Figure 68. Intertek Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026) Figure 69. ALS Limited Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026) Figure 70. Microbac Laboratories Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026) Figure 71. Alcami Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026) Figure 72. Almac Group Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026) Figure 73. Labcorp Drug Development Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026) Figure 74. Element Materials Technology Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026) Figure 75. Toxikon Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026) Figure 76. Aurigene Pharmaceutical Services Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026) Figure 77. Toray Research Center Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026) Figure 78. Centre Testing International Group Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026) Figure 79. Pony Testing International Group Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026) Figure 80. Sumika Chemical Analysis Service Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026) Figure 81. CMIC Group Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026) Figure 82. LSI Medience Revenue Growth Rate in Pharmaceutical Microbiology Testing Business (2021-2026)

Scope & coverage.

Types
  • Culture-Based Testing
  • Rapid Microbial Testing
  • Molecular Testing
  • Automated Microbiology Testing
  • Others
Applications
  • Pharmaceutical Industry
  • CRO/CDMO
  • Medical Device
  • Others
Companies covered
  • Eurofins Scientific
  • Charles River Laboratories
  • SGS
  • WuXi AppTec
  • Nelson Labs
  • Pace Analytical
  • Thermo Fisher Scientific
  • Merck KGaA / MilliporeSigma
  • bioMérieux
  • Sartorius
  • STERIS
  • Intertek
  • ALS Limited
  • Microbac Laboratories
  • Alcami
  • Almac Group
  • Labcorp Drug Development
  • Element Materials Technology
  • Toxikon
  • Aurigene Pharmaceutical Services
  • Toray Research Center
  • Centre Testing International Group
  • Pony Testing International Group
  • Sumika Chemical Analysis Service
  • CMIC Group
  • LSI Medience

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Pharmaceutical Microbiology Testing by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Culture-Based Testing
  5. 2.2.3 Rapid Microbial Testing
  6. 2.2.4 Molecular Testing
  7. 2.2.5 Automated Microbiology Testing
  8. 2.2.6 Others
  9. 2.3 Pharmaceutical Microbiology Testing by Application
  10. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  11. 2.3.2 Pharmaceutical Industry
  12. 2.3.3 CRO/CDMO
  13. 2.3.4 Medical Device
  14. 2.3.5 Others
  15. 2.4 Assumptions and Limitations
3 Pharmaceutical Microbiology Testing Breakdown Data by Type
  1. 3.1 Global Pharmaceutical Microbiology Testing Historic Market Size by Type (2021-2026)
  2. 3.2 Global Pharmaceutical Microbiology Testing Forecasted Market Size by Type (2027-2032)
4 Pharmaceutical Microbiology Testing Breakdown Data by Application
  1. 4.1 Global Pharmaceutical Microbiology Testing Historic Market Size by Application (2021-2026)
  2. 4.2 Global Pharmaceutical Microbiology Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Pharmaceutical Microbiology Testing Market Perspective (2021-2032)
  2. 5.2 Global Pharmaceutical Microbiology Testing Growth Trends by Region
  3. 5.2.1 Global Pharmaceutical Microbiology Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Pharmaceutical Microbiology Testing Historic Market Size by Region (2021-2026)
  5. 5.2.3 Pharmaceutical Microbiology Testing Forecasted Market Size by Region (2027-2032)
  6. 5.3 Pharmaceutical Microbiology Testing Market Dynamics
  7. 5.3.1 Pharmaceutical Microbiology Testing Industry Trends
  8. 5.3.2 Pharmaceutical Microbiology Testing Market Drivers
  9. 5.3.3 Pharmaceutical Microbiology Testing Market Challenges
  10. 5.3.4 Pharmaceutical Microbiology Testing Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Pharmaceutical Microbiology Testing Players by Revenue
  2. 6.1.1 Global Top Pharmaceutical Microbiology Testing Players by Revenue (2021-2026)
  3. 6.1.2 Global Pharmaceutical Microbiology Testing Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Pharmaceutical Microbiology Testing Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Pharmaceutical Microbiology Testing Head Office and Area Served
  6. 6.4 Global Pharmaceutical Microbiology Testing Players, Product Type & Application
  7. 6.5 Global Pharmaceutical Microbiology Testing Manufacturers Established Date
  8. 6.6 Global Pharmaceutical Microbiology Testing Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Pharmaceutical Microbiology Testing Market Size (2021-2032)
  2. 7.2 North America Pharmaceutical Microbiology Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Pharmaceutical Microbiology Testing Market Size by Country (2021-2026)
  4. 7.4 North America Pharmaceutical Microbiology Testing Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Pharmaceutical Microbiology Testing Market Size (2021-2032)
  2. 8.2 Europe Pharmaceutical Microbiology Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Pharmaceutical Microbiology Testing Market Size by Country (2021-2026)
  4. 8.4 Europe Pharmaceutical Microbiology Testing Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Pharmaceutical Microbiology Testing Market Size (2021-2032)
  2. 9.2 Asia-Pacific Pharmaceutical Microbiology Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Pharmaceutical Microbiology Testing Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Pharmaceutical Microbiology Testing Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Pharmaceutical Microbiology Testing Market Size (2021-2032)
  2. 10.2 South America Pharmaceutical Microbiology Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Pharmaceutical Microbiology Testing Market Size by Country (2021-2026)
  4. 10.4 South America Pharmaceutical Microbiology Testing Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Pharmaceutical Microbiology Testing Market Size (2021-2032)
  2. 11.2 Middle East & Africa Pharmaceutical Microbiology Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Pharmaceutical Microbiology Testing Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Pharmaceutical Microbiology Testing Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Eurofins Scientific
  2. 12.1.1 Eurofins Scientific Company Information
  3. 12.1.2 Eurofins Scientific Business Overview
  4. 12.1.3 Eurofins Scientific Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  5. 12.1.4 Eurofins Scientific Pharmaceutical Microbiology Testing Product Portfolio
  6. 12.1.5 Eurofins Scientific Recent Developments
  7. 12.2 Charles River Laboratories
  8. 12.2.1 Charles River Laboratories Company Information
  9. 12.2.2 Charles River Laboratories Business Overview
  10. 12.2.3 Charles River Laboratories Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  11. 12.2.4 Charles River Laboratories Pharmaceutical Microbiology Testing Product Portfolio
  12. 12.2.5 Charles River Laboratories Recent Developments
  13. 12.3 SGS
  14. 12.3.1 SGS Company Information
  15. 12.3.2 SGS Business Overview
  16. 12.3.3 SGS Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  17. 12.3.4 SGS Pharmaceutical Microbiology Testing Product Portfolio
  18. 12.3.5 SGS Recent Developments
  19. 12.4 WuXi AppTec
  20. 12.4.1 WuXi AppTec Company Information
  21. 12.4.2 WuXi AppTec Business Overview
  22. 12.4.3 WuXi AppTec Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  23. 12.4.4 WuXi AppTec Pharmaceutical Microbiology Testing Product Portfolio
  24. 12.4.5 WuXi AppTec Recent Developments
  25. 12.5 Nelson Labs
  26. 12.5.1 Nelson Labs Company Information
  27. 12.5.2 Nelson Labs Business Overview
  28. 12.5.3 Nelson Labs Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  29. 12.5.4 Nelson Labs Pharmaceutical Microbiology Testing Product Portfolio
  30. 12.5.5 Nelson Labs Recent Developments
  31. 12.6 Pace Analytical
  32. 12.6.1 Pace Analytical Company Information
  33. 12.6.2 Pace Analytical Business Overview
  34. 12.6.3 Pace Analytical Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  35. 12.6.4 Pace Analytical Pharmaceutical Microbiology Testing Product Portfolio
  36. 12.6.5 Pace Analytical Recent Developments
  37. 12.7 Thermo Fisher Scientific
  38. 12.7.1 Thermo Fisher Scientific Company Information
  39. 12.7.2 Thermo Fisher Scientific Business Overview
  40. 12.7.3 Thermo Fisher Scientific Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  41. 12.7.4 Thermo Fisher Scientific Pharmaceutical Microbiology Testing Product Portfolio
  42. 12.7.5 Thermo Fisher Scientific Recent Developments
  43. 12.8 Merck KGaA / MilliporeSigma
  44. 12.8.1 Merck KGaA / MilliporeSigma Company Information
  45. 12.8.2 Merck KGaA / MilliporeSigma Business Overview
  46. 12.8.3 Merck KGaA / MilliporeSigma Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  47. 12.8.4 Merck KGaA / MilliporeSigma Pharmaceutical Microbiology Testing Product Portfolio
  48. 12.8.5 Merck KGaA / MilliporeSigma Recent Developments
  49. 12.9 bioMérieux
  50. 12.9.1 bioMérieux Company Information
  51. 12.9.2 bioMérieux Business Overview
  52. 12.9.3 bioMérieux Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  53. 12.9.4 bioMérieux Pharmaceutical Microbiology Testing Product Portfolio
  54. 12.9.5 bioMérieux Recent Developments
  55. 12.10 Sartorius
  56. 12.10.1 Sartorius Company Information
  57. 12.10.2 Sartorius Business Overview
  58. 12.10.3 Sartorius Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  59. 12.10.4 Sartorius Pharmaceutical Microbiology Testing Product Portfolio
  60. 12.10.5 Sartorius Recent Developments
  61. 12.11 STERIS
  62. 12.11.1 STERIS Company Information
  63. 12.11.2 STERIS Business Overview
  64. 12.11.3 STERIS Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  65. 12.11.4 STERIS Pharmaceutical Microbiology Testing Product Portfolio
  66. 12.11.5 STERIS Recent Developments
  67. 12.12 Intertek
  68. 12.12.1 Intertek Company Information
  69. 12.12.2 Intertek Business Overview
  70. 12.12.3 Intertek Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  71. 12.12.4 Intertek Pharmaceutical Microbiology Testing Product Portfolio
  72. 12.12.5 Intertek Recent Developments
  73. 12.13 ALS Limited
  74. 12.13.1 ALS Limited Company Information
  75. 12.13.2 ALS Limited Business Overview
  76. 12.13.3 ALS Limited Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  77. 12.13.4 ALS Limited Pharmaceutical Microbiology Testing Product Portfolio
  78. 12.13.5 ALS Limited Recent Developments
  79. 12.14 Microbac Laboratories
  80. 12.14.1 Microbac Laboratories Company Information
  81. 12.14.2 Microbac Laboratories Business Overview
  82. 12.14.3 Microbac Laboratories Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  83. 12.14.4 Microbac Laboratories Pharmaceutical Microbiology Testing Product Portfolio
  84. 12.14.5 Microbac Laboratories Recent Developments
  85. 12.15 Alcami
  86. 12.15.1 Alcami Company Information
  87. 12.15.2 Alcami Business Overview
  88. 12.15.3 Alcami Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  89. 12.15.4 Alcami Pharmaceutical Microbiology Testing Product Portfolio
  90. 12.15.5 Alcami Recent Developments
  91. 12.16 Almac Group
  92. 12.16.1 Almac Group Company Information
  93. 12.16.2 Almac Group Business Overview
  94. 12.16.3 Almac Group Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  95. 12.16.4 Almac Group Pharmaceutical Microbiology Testing Product Portfolio
  96. 12.16.5 Almac Group Recent Developments
  97. 12.17 Labcorp Drug Development
  98. 12.17.1 Labcorp Drug Development Company Information
  99. 12.17.2 Labcorp Drug Development Business Overview
  100. 12.17.3 Labcorp Drug Development Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  101. 12.17.4 Labcorp Drug Development Pharmaceutical Microbiology Testing Product Portfolio
  102. 12.17.5 Labcorp Drug Development Recent Developments
  103. 12.18 Element Materials Technology
  104. 12.18.1 Element Materials Technology Company Information
  105. 12.18.2 Element Materials Technology Business Overview
  106. 12.18.3 Element Materials Technology Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  107. 12.18.4 Element Materials Technology Pharmaceutical Microbiology Testing Product Portfolio
  108. 12.18.5 Element Materials Technology Recent Developments
  109. 12.19 Toxikon
  110. 12.19.1 Toxikon Company Information
  111. 12.19.2 Toxikon Business Overview
  112. 12.19.3 Toxikon Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  113. 12.19.4 Toxikon Pharmaceutical Microbiology Testing Product Portfolio
  114. 12.19.5 Toxikon Recent Developments
  115. 12.20 Aurigene Pharmaceutical Services
  116. 12.20.1 Aurigene Pharmaceutical Services Company Information
  117. 12.20.2 Aurigene Pharmaceutical Services Business Overview
  118. 12.20.3 Aurigene Pharmaceutical Services Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  119. 12.20.4 Aurigene Pharmaceutical Services Pharmaceutical Microbiology Testing Product Portfolio
  120. 12.20.5 Aurigene Pharmaceutical Services Recent Developments
  121. 12.21 Toray Research Center
  122. 12.21.1 Toray Research Center Company Information
  123. 12.21.2 Toray Research Center Business Overview
  124. 12.21.3 Toray Research Center Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  125. 12.21.4 Toray Research Center Pharmaceutical Microbiology Testing Product Portfolio
  126. 12.21.5 Toray Research Center Recent Developments
  127. 12.22 Centre Testing International Group
  128. 12.22.1 Centre Testing International Group Company Information
  129. 12.22.2 Centre Testing International Group Business Overview
  130. 12.22.3 Centre Testing International Group Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  131. 12.22.4 Centre Testing International Group Pharmaceutical Microbiology Testing Product Portfolio
  132. 12.22.5 Centre Testing International Group Recent Developments
  133. 12.23 Pony Testing International Group
  134. 12.23.1 Pony Testing International Group Company Information
  135. 12.23.2 Pony Testing International Group Business Overview
  136. 12.23.3 Pony Testing International Group Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  137. 12.23.4 Pony Testing International Group Pharmaceutical Microbiology Testing Product Portfolio
  138. 12.23.5 Pony Testing International Group Recent Developments
  139. 12.24 Sumika Chemical Analysis Service
  140. 12.24.1 Sumika Chemical Analysis Service Company Information
  141. 12.24.2 Sumika Chemical Analysis Service Business Overview
  142. 12.24.3 Sumika Chemical Analysis Service Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  143. 12.24.4 Sumika Chemical Analysis Service Pharmaceutical Microbiology Testing Product Portfolio
  144. 12.24.5 Sumika Chemical Analysis Service Recent Developments
  145. 12.25 CMIC Group
  146. 12.25.1 CMIC Group Company Information
  147. 12.25.2 CMIC Group Business Overview
  148. 12.25.3 CMIC Group Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  149. 12.25.4 CMIC Group Pharmaceutical Microbiology Testing Product Portfolio
  150. 12.25.5 CMIC Group Recent Developments
  151. 12.26 LSI Medience
  152. 12.26.1 LSI Medience Company Information
  153. 12.26.2 LSI Medience Business Overview
  154. 12.26.3 LSI Medience Revenue in Pharmaceutical Microbiology Testing Business (2021-2026)
  155. 12.26.4 LSI Medience Pharmaceutical Microbiology Testing Product Portfolio
  156. 12.26.5 LSI Medience Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst